Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
All >

News > Switzerland

Total search results: 2248 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Anergis S.A.. (2/5/14). "Press Release: Anergis Closes Financing Round Totaling CHF 8 M. Preparation of Phase III Trials with Lead Allergy Vaccine AllerT". Epalinges, CH. 2014-02-05
Actelion Ltd.. (1/31/13). "Press Release: Actelion Launches Opsumit in Germany". Allschwil. 2014-01-31
F. Hoffmann-La Roche AG. (1/30/14). "Press Release: Roche Delivers Strong 2013 Results. Group Sales Rise 6% to 46.8 Billion Swiss Francs". Basel. 2014-01-30
Novartis AG. (1/29/14). "Press Release: Novartis Delivers Strong Sales and Innovation in 2013 – Underlying Business Performance Reinforces Growth Prospects". Basel. 2014-01-29
InSphero AG. (1/28/14). "Press Release: InSphero Hires New Director of Global Marketing". Schlieren. 2014-01-28
Prothena Corporation plc. (1/23/14). "Press Release: Prothena to Receive $30 Million Upfront Payment from Roche Triggered by the Expiration of Hart-Scott-Rodino Waiting Period". Dublin. 2014-01-23
Lonza Group Ltd.. (1/23/14). "Press Release: Lonza Delivers Strong Results Following Continuing Success of Transformation Efforts". 2014-01-23
Roche. (1/23/14). "Press Release: Juan Carlos Lopez Appointed Head of Academic Relations & Collaborations at Roche. The Former Chief Editor at Nature Medicine to Spearhead Roche pRED’s Relations with Academic and Non-profit Research Organizations". Basel 2014-01-23
A*STAR. (1/22/14). "Press Release: A*STAR Signs Agreement with Nestlé to Strengthen Food & Nutrition R&D in Singapore". 2014-01-22
Nestlé S.A.. (1/22/14). "Press Release: Nestlé Signs Research Agreement with Singapore". 2014-01-22
Piqur Therapeutics AG. (1/21/14). "Press Release: Piqur Launches Phase I Study with Its Lead Compound PQR309 and Successfully Completes Series A Financing Round". 2014-01-14
Incyte Corporation. (1/13/14). "Press Release: Incyte Names Hervé Hoppenot President and Chief Executive Officer. Former President of Novartis Oncology to Lead Incyte’s Future Growth". Wilmington, DE. 2014-01-13
Solvias AG. (1/13/14). "Press Release: Solvias Appoints New CEO". 2014-01-13
Lonza Group Ltd.. (1/13/14). "Press Release: Lonza Extends Partnership with Pharmacyclics to Support Manfacturing a Recently Approved Oncology Therapeutic, Imbruvica". Basel. 2014-01-13
Agenus Inc.. (1/13/14). "Press Release: Agenus Enters into Definitive Agreement to Acquire Privately Held 4-Antibody AG". Lexington, MA. 2014-01-13
Biognosys AG. (1/10/14). "Press Release: New Financing and Extension of Biognosys’ Management Team". 2014-01-10
Nuevolution A/S. (1/10/14). "Press Release: Nuevolution Announces Technology Licensing Agreement". Copenhagen. 2014-01-10
AC Immune S.A.. (1/9/14). "Press Release: AC Immune Raises CHF 20 Million and Initiates World’s First anti-pTau Vaccine Trial for Alzheimer’s Disease". Lausanne. 2014-01-09
Aravis. (1/9/14). "Press Release: Aravis Strengthens Life Science Team with Three Important Appointments". Zurich. 2014-01-09
Lonza Group Ltd.. (1/9/14). "Press Release: Lonza Signs Exclusive Agreement with Index Ventures for the Development and Manufacture of Biologics for Portfolio Companies". Basel & London. 2014-01-09
Santaris Pharma A/S. (1/9/14). "Press Release: Santaris A/S Announces Worldwide Discovery Alliance for RNA-targeted Medicines with Roche". Hørsholm & San Diego, CA. 2014-01-09
Cellular Dynamics International, Inc.. (1/8/14). "Press Release: Cellular Dynamics Signs Agreement with Nestle Institute of Health Sciences to Supply iCell and MyCell Products for Nutritional Research". Madison, WI. 2014-01-08
Actelion Ltd.. (12/20/13). "Press Release: Actelion Is Granted Marketing Authorisation for Opsumit (macitentan) in Pulmonary Arterial Hypertension (PAH) by the European Commission". Allschwil. 2013-12-20
Prothena Corporation plc. (12/11/13). "Press Release: Roche and Prothena Enter into Worldwide Collaboration to Co-develop and Co-promote Antibodies for Treatment of Parkinson’s Disease". Basel & Dublin. 2013-12-11
Genedata AG. (12/10/13). "Press Release: New Genedata Expressionist for MS Gains Increased Adoption in Metabolomics R&D". Basel. 2013-12-10
Covagen AG. (12/9/13). "Press Release: Covagen Secures CHF 42 Million in Series B Financing". Zürich-Schlieren. 2013-12-09
Biocartis S.A.. (12/6/13). "Press Release: Biocartis and VIB Join Forces to Develop Unique Diagnostic Cancer Test". Mechelen & Lausanne. 2013-12-06
Novartis AG. (12/6/13). "Press Release: Novartis Investigational Compound LBH589 Significantly Extended Time without Disease Progression in Phase III Multiple Myeloma Study". Basel. 2013-12-06
Evolva Holding S.A.. (12/5/13). "Press Release: Evolva to Participate in European Research Project". Reinach. 2013-12-05
Roche. (12/4/13). "Press Release: Roche and Molecular Partners Enter into Alliance to Develop New Cancer Treatments. Partnership Will Combine Novel Biologics (DARPins) with Roche Drug-conjugate Technology". Basel & Zürich-Schlieren. 2013-12-04
Redbiotec AG. (12/3/13). "Press Release: Collaboration with GSK Vaccines". Schlieren. 2013-12-03
Genedata AG. (12/3/13). "Press Release: Genedata Announces Collaboration with AstaZeneca on the Analysis of Compound Combination Experiments". Basel. 2013-12-03
Actelion Ltd.. (12/2/13). "Press Release: Update on the DUAL Program in Digital Ulcers in Systemic Sclerosis". Allschwil. 2013-12-02
Telormedix S.A.. (12/2/13). "Press Release: Telormedix Raises CHF 6 M ($6.6 M) in Series B Financing Round". Bioggio, TI. 2013-12-02
Biocartis S.A.. (11/28/13). "Press Release: Biocartis Announces the End of Its Alliance with bioMérieux". Mechelen & Lausanne. 2013-11-28
bioMérieux S.A.. (11/28/13). "Press Release: bioMérieux Announces Termination of Its Collaboration with Biocartis in Molecular Biology". Marcy l’Étoile. 2013-11-28
InSphero AG. (11/25/13). "Press Release: InSphero’s New EU Subsidiary Opens for Business". Schlieren. 2013-11-25
Covagen AG. (11/21/13). "Press Release: Covagen and Tanabe Research Laboratories Expand Strategic Research Collaboration for Development of Bispecific FynomAbs". Zürich-Schlieren. 2013-11-21
Eloxx Pharmaceuticals, Ltd.. (11/21/13). "Press Release: Eloxx Pharmaceuticals, Ltd. Announced the Initial Closing of its First Round of Financing". Herzliya. 2013-11-21
Selexis S.A.. (11/19/13). "Press Release: Selexis SA Names Dr. Marco Bocci Director of European Sales and Business Development". Geneva. 2013-11-19
Cytos Biotechnology AG. (11/18/13). "Press Release: Rights Offering Oversubscribed – CHF 24.3 Million Raised". Schlieren. 2013-11-18
Basilea Pharmaceutica Ltd.. (11/18/13). "Press Release: Basilea Reports Isavuconazole Orphan Drug Designation for Treatment of Zygomycosis by U.S. FDA". Basel. 2013-11-18
InSphero AG. (11/18/13). "Press Release: Cambridge Bioscience Our New Distributor for the UK". 2013-11-18
Immunocore Ltd.. (11/14/13). "Press Release: Immunocore Appoints Dr Jonathan Knowles as Chairman of the Board". Oxford. 2013-11-14
Immatics Biotechnologies GmbH. (11/13/13). "Press Release: Immatics and Roche Sign Cancer Vaccine and Immunotherapy Collaboration". Tübingen & Basel. 2013-11-13
Novartis AG. (11/11/13). "Press Release: Novartis Announces Divestiture of Its Blood Transfusion Diagnostics Unit to Grifols. Spain-based Grifols to Acquire Novartis Blood Transfusion Diagnostics Unit for USD 1.675 Billion". Basel. 2013-11-11
Biocartis S.A.. (11/5/13). "Press Release: Biocartis Poised for 2014 Commercial Launch with EUR 30 Million Series E Equity Fundraising". Mechelen & Lausanne. 2013-11-05
ADC Therapeutics S.a.r.l.. (11/5/13). "Press Release: ADC Therapeutics Licenses Proprietary Antibodies from Five Prime Therapeutics, Adds an Additional Proprietary ADC Development Program in Oncology". Lausanne & South San Francisco, CA. 2013-11-05
CureVac GmbH. (11/4/13). "Press Release: CureVac Collaborates with the Cancer Research Institute and Ludwig Cancer Research to Enalbe Clinical Testing of Novel Immunotherapy Treatment Options for Cancer". Tübingen & New York, NY. 2013-11-04
Roche. (11/4/13). "Press Release: Roche and Polyphor Join Efforts to Combat Multi-drug-resistant Bacterial Infections". Basel. 2013-11-04
Biognosys AG. (11/1/13). "Press Release: New Release of iRT Kit". 2013-11-01
Anton Paar GmbH. (11/13). "Press Release: Anton Paar GmbH Acquires CSM Instruments SA". 2013-11-01
Genedata AG. (10/30/13). "Press Release: Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support". Basel. 2013-10-30
ETH Zürich. (10/29/13). "Press Release: An Artificial Enzyme that Promotes 700 Reactions per Second". 2013-10-29
Tecan Group Ltd.. (10/29/13). "Press Release: Tecan’s AC Extraction Plate Provides a Unique Sample Preparation Tool for LC-MS". Männedorf. 2013-10-29
Biognosys AG. (10/25/13). "Press Release: SWATH Enabling Software Spectronaut Referenced in Recent Publications". 2013-10-25
Basilea Pharmaceutica Ltd.. (10/23/13). "Press Release: Basilea’s Antibiotic Ceftobiprole Obtains Regulatory Approval in Europe for Pneumonia". Basel. 2013-10-23
Biocartis S.A.. (10/22/13). "Press Release: Biocartis Presents the Successful Use of Idylla for the Detection of BRAF Mutation Status in Tumour Samples at the International AACR Congress in Boston". Mechelen & Lausanne. 2013-10-22
Finox AG (Finox Biotech). (10/22/13). "Press Release: Finox Biotech Shareholders Agree Capital Increase". Burgdorf. 2013-10-22
Novartis AG. (10/22/13). "Press Release: Novartis Delivers Strong Sales Performance in Third Quarter Driven by Growth Products’ Momentum – Innovation Newsflow Reinforces Growth Prospects". Basel. 2013-10-22
Samsung BioLogics. (10/22/13). "Press Release: Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche". Seoul. 2013-10-22
Tecan Group Ltd.. (10/22/13). "Press Release: Enhancing Clinical Diagnostics with Tecan’s Cavro OmniRobot". Männedorf. 2013-10-22
Biognosys AG. (10/18/13). "Press Release: US Patent Awarded to Biognosys". 2013-10-18
Actelion Ltd.. (10/18/13). "Press Release: Actelion Receives US FDA Approval for Opsumit (macitentan) for the Treatment of Pulmonary Arterial Hypertension". Allschwil. 2013-10-18
Actelion Ltd.. (10/17/13). "Press Release: Actelion on Track to Deliver Double Digit LC Core Earnings Growth". Allschwil. 2013-10-17
Biocartis S.A.. (10/17/13). "Press Release: Biocartis and Hospital del Mar Join Forces to Develop Diagnostic Colon Cancer Test". Lausanne, Mechelen & Barcelona. 2013-10-17
Biodesy, Inc.. (10/17/13). "Press Release: Biodesy Inc. Completes $15.0 Million Series A Financing and Appoints Greg Yap as Chief Executive Officer. Series A Investors include 5AM Ventures, Pfizer Venture Investments and Roche Venture". Burlingame, CA. 2013-10-17
Roche. (10/17/13). "Press Release: Roche Posts Strong Sales Growth in the First Nine Months of 2013". Basel. 2013-10-17
Roche. (10/14/13). "Press Release: Roche to Invest 800 Million Swiss Francs in Global Biologic Medicine Manufacturing Network". Basel. 2013-10-14
ImmunoGen, Inc.. (10/11/13). "Press Release: ImmunoGen, Inc. Announces New License Agreement". Waltham, MA. 2013-10-11
Cytos Biotechnology AG. (10/10/13). "Press Release: Cytos Biotechnology Plans Financing of up to CHF 17.6 Million. CHF 9 Million of Proposed Capital Increase Already Firmly Committed by Existing Investors". Schlieren. 2013-10-10
Curetis AG. (10/9/13). "Press Release: Curetis Presents New Clinical Validation Data on Its Unyvero P50 Pneumonia / LRT Application". Holzgerlingen. 2013-10-09
Tecan Group Ltd.. (10/9/13). "Press Release: Tecan Maintains Target for Profitability and Adjusts Revenue Guidance for 2013". Männedorf. 2013-10-09
Debiopharm S.A.. (10/7/13). "Press Release: Experimental Therapeutics Centre and Debiopharm Group to Collaborate for the Development of an Epigenetic Innovative Oncology Target". Singapore & Lausanne. 2013-10-07
Acino Holding AG. (10/2/13). "Press Release: Avista Capital Partners and Nordic Capital to Launch a Joint Public Tencer Offer to Acquire Acino. Offer Price of CHF 115.00 Represents a 33% Premium to the Closing Share Price on October 1, 2013". Aesch. 2013-10-02
MorphoSys AG. (10/2/13). "Press Release: MorphoSys Collaborator to Start Pivotal Study with Bimagrumab. MorphoSys to Receive Clinical Milestone Payment". 2013-10-02
EffRx Pharmaceuticals S.A.. (10/1/13). "Press Release: EffRx Receives Prestigious EUR 5.9 Million FP7 Research Grant for the Development of EX404 for PolyCystic Ovary Syndrome (PCOS) in Paediatric Populations". Freienbach. 2013-10-01
Dualsystems Biotech AG. (9/30/13). "Press Release: Dualsystems Biotech Closes Series C Financing Round". 2013-09-30
Basilea Pharmaceutica Ltd.. (9/30/13). "Press Release: Basilea Reports Positive Topline Phase 3 Results for Antifungal Isavuconazole". Basel. 2013-09-30
Biognosys AG. (9/27/13). "Press Release: New MRM Panel for Dried Blood Spot Samples". 2013-09-27
M+W Group. (9/27/13). "Press Release: M+W Group Hands Over Most Advanced Research Laboratory to Nestlé". 2013-09-27
Actelion Ltd.. (9/19/13). "Press Release: Actelion Closes Acquisition of Privately-held Ceptaris Therapeutics Adding Valchlor to Actelion’s Product Portfolio. Valchlor Is the Only FDA-approved Topical Formulation of Mechlorethamine". Allschwil. 2013-09-19
BioGenes GmbH. (9/18/13). "Press Release: BioGenes Launches Enhanced Generic HCP Assay for Early Stage Biologics Production". Berlin. 2013-09-18
Addex Therapeutics S.A.. (9/17/13). "Press Release: Addex Therapeutics First Half 2013 Financial Results". Geneva. 2013-09-17
Genedata AG. (9/17/13). "Press Release: Evonik and Genedata Broaden Their Collaboration with the Genedata Selector Biotechnology Data Management Platform". Basel. 2013-09-17
Roche. (9/16/13). "Press Release: Christoph Franz Nominated to Become New Roche Chairman". Basel. 2013-09-16
Inovio Pharmaceuticals, Inc.. (9/10/13). "Press Release: Roche and Inovio Pharmaceuticals Partner On Inovio’s Prostate and Hepatitis B Immunotherapy Products". Basel & Blue Bell, PA. 2013-09-10
Debiopharm S.A.. (9/9/13). "Press Release: Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm". Lausanne & Kolkata. 2013-09-09
Evolva Holding S.A.. (9/9/13). "Press Release: Cargill and Evolva Move into Pilot Scale ahead of Schedule for Fermentation-based Steviol Glycosides". Minneapolis, MN & Reinach. 2013-09-09
Genkyotex S.A.. (9/9/13). "Press Release: Genkyotex Receives FDA IND Approval for Phase II Clinical Study with First in Class NOX Inhibitor GTK137831". Geneva & Archamps. 2013-09-09
Bruker Corporation. (9/9/13). "Press Release: Bruker Introduces New Benchtop FT-NMR System Fourier 60". Indianapolis, IN. 2013-09-09
Novartis AG. (9/6/13). "Press Release: Novartis Announces an Exclusive Global Licensing and Research Collaboration with Regenerex, Leveraging a Novel Cell Platform to Broaden Presence in the Cell Therapy Space". Basel. 2013-09-06
Debiopharm S.A.. (9/5/13). "Press Release: Go To Market Consulting Inc. and Debiopharm Group Collaborate to Identify Early Stage In-licensing Opportunities on the US West Coast". Lausanne & San Francisco, CA. 2013-09-05
Piqur Therapeutics AG. (9/5/13). "Press Release: Piqur Successfully Closed a Third Seed Financing Round and Received Eurostars Grant". Basel. 2013-09-05
Analytik Jena AG. (9/4/13). "Press Release: Analytik Jena AG Approves a Subscription Rights Capital Increase of up to 1.95 Million New Shares (Ad-hoc notification in accordance with Section 15 WpHG [Securities Trading Act])". Jena. 2013-09-04
Genedata AG. (9/4/13). "Press Release: Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening". Basel. 2013-09-04
Roche. (9/4/13). "Press Release: Start of the TROPICAL-ACS Large Intervention Study on Multiplate-guided Anti-platelet Therapy in ACS Patients". Rotkreuz. 2013-09-04
Santhera Pharmaceuticals. (9/3/13). "Press Release: Santhera Closes License-back Deal with Takeda for European Rights to Catena in Duchenne Muscular Dystrophy". Liestal. 2013-09-03
Zealand Pharma A/S. (9/3/13). "Press Release: Zealand Appoints New Chief Scientific Officer. Dr Torsten Hoffmann Joins from Roche". Copenhagen. 2013-09-03
Genedata AG. (9/3/13). "Press Release: Genedata Screener Extends Support for High-throughput Thermofluor Assays". Basel. 2013-09-03
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page


Picture Fairtec GmbH We Optimise the ROI of Your Event 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75

» top